COVID-19 pandemic has turned out to be a major growth determinant in the industrial automation sector. With the integration of digital infrastructure to monitor and control public health, industrial automation has taken a new shape. This crisis has enhanced the value of IT and digital transformation across different sectors and industries.
The medical devices industry in the past decade has witnessed unprecedented growth owing to improved and innovative technologies and the development of state-of-the-art infrastructural facilities. Technologies such as 3D printing offer market players a plethora of growth opportunities in the field of personalized medicine. Faster regulatory approvals and consistent R&D activities have had a positive impact on the medical devices as well as pharmaceutical industry.
Transbronchial needle aspiration (TBNA) is mainly used to obtain the core or cellular biopsy tissue from the lung lesions which are accessible by bronchoscopy. The TBNA is used to examine subclinical and parabronchial nodules as well as parenchymal abnormalities. The standard TBNA procedure uses a 21-G cytology needle or a 19-G histology needle with a flexible bronchovideo scope. Bronchoscopy is being used by the operator to direct the target lesion like lymph node or lung mass. The transbronchial needle is then passed through the working channel of the bronchoscope.
To Understand How Our Report Information Can Bring Difference, Ask for a brochure @ https://www.persistencemarketresearch.com/samples/22855
Through this the bronchial wall and the material is aspirated for histological analysis. Initially transbronchial needle aspiration was developed as a technique for the hilar lymph node and mediastinal biopsy. Transbronchial needle aspiration technique offered pulmonologists a minimally invasive technique for the treatment of mediastinal non-small cell lung cancer. Transbronchial needle aspiration worked as an alternative technique to surgical mediastinoscopy. Transbronchial needle aspiration is used in aspiration in paratracheal, carinal, and hilar lesions where the biopsy forceps cannot obtain a submucosal sample. Transbronchial needle aspiration is a minimally invasive, safe and cost effective method for the diagnoses of mediastinal or peripheral pathologies.
According to American Lung Association, lung cancer is the most common cancer worldwide which accounted for 1.8 million new cases and 1.6 million deaths in 2012. The National Institutes of Health estimates that the cancer care cost the U.S. an overall $147.5 billion in 2015, $13.4 billion of which is due to lung cancer. An estimated 158,080 Americans are expected to die from lung cancer in 2016, accounting for approximately 27 percent of all cancer deaths.
Market for transbronchial needle aspiration is primarily driven by increasing incidences of lung diseases worldwide. Lung cancer is the leading cause of cancer deaths around the world. In addition, increasing habit of smoking and technological advancements are also some of the factors which are increasing the demand for less invasive procedures and thus driving the growth of the global transbronchial needle aspiration market. However, less available treatment opportunities in the developing countries can hamper the growth of global transbronchial needle aspiration market.
The global market for transbronchial needle aspiration market is segmented on basis of application, end user and geography:
- Segmentation by Product type
- Endobronchial ultrasound-guided TBNA (EBUS-TBNA)
- Conventional TBNA (C-TBNA)
- Segmentation by Application
- Lymphatic Diseases
- Lung Cancer
- Others
- Segmentation by End User
- Hospitals
- Ambulatory Surgical Centers
- Cancer centers
- Others
Looking for Exclusive Market Insights from Business Experts? Request a Custom Report here @ https://www.persistencemarketresearch.com/request-customization/22855
Among application type, lung cancer is expected to dominate the global transbronchial needle aspiration market. Among all end users of transbronchial needle aspiration, hospital is expected to experience highest growth over the forecast period. Based on product type, the market is segmented into Endobronchial ultrasound-guided TBNA (EBUS-TBNA) and Conventional TBNA (C-TBNA). Endobronchial ultrasound-guided TBNA is currently more difficult and complicated technique. Due to the real time nature of the Endobronchial ultrasound-guided TBNA pulmonologists are taking more interest in the field of interventional pulmonology.
On the basis of geography, global transbronchial needle aspiration market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The market in North America is expected to show the largest market share for transbronchial needle aspiration, followed by Europe, owing to the high adoption rate of technologically advanced devices. The Asia-Pacific market is estimated to grow at fastest CAGR over the forecast period owing to the presence of large population base coupled with the high proportion of the geriatric population. However, the transbronchial needle aspiration market in Middle East & Africa shows a steady growth during the forecast period due to the presence of inadequate healthcare infrastructure and scarcity of professionals.
Some of the key players present in global transbronchial needle aspiration market are Olympus America, Boston Scientific Corporation, Medi-Globe GmbH and others.
To Gain More Insights & Stay Ahead Of The Competition, Buy Now @ https://www.persistencemarketresearch.com/checkout/22855
The report covers exhaustive analysis on:
- Transbronchial Needle Aspiration Market Segments
- Transbronchial Needle Aspiration Market Dynamics
- Historical Actual Market Size, 2012 – 2016
- Transbronchial Needle Aspiration Market Size & Forecast 2016 to 2024
- Transbronchial Needle Aspiration Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Transbronchial Needle Aspiration Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
Mr. Rajendra Singh
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
No comments:
Post a Comment